TLE3 binds FOXA1 to inhibit the expression of ER target genes in breast cancer cells, which may explain the influence of TLE3 on the sensitivity of tumor cells to tamoxifen treatment (Jangal et al., 2014). This evidence concerns the gene ESR1 and breast carcinoma.